Topiramate is now contraindicated in pregnancy and in women of childbearing potential unless the conditions of a Pregnancy Prevention Programme are fulfilled. This follows a review by the MHRA which concluded that the use of…
This content is sourced from MHRA and reproduced for clinical reference. ClinicalIQ does not alter source content.